PDZ2b domain of PTP-Bas (hPTP1E)
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 1357–1464 | Not recorded | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 6.8;293 K;Ionic strength (raw mmCIF value) 50mM sodium phosphate, 150mM sodium chloride;Pressure ambient NMR sample composition:2mM PDZ2b U-15N, 13C; 50mM phosphate buffer with 150mM sodium chloride | 92% H20, 8% D2O NMR sample composition:2mM PDZ2b U-15N; 50mM phosphate buffer with 150mM sodium chloride | 92% H20, 8% D2O NMR sample composition:2mM PDZ2b unlabeled; 50mM phosphate buffer with 150mM sodium chloride | 92% H20, 8% D2O | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1Q7X | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1D5G SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E COMPLEXED WITH A PEPTIDE Deposited 1999-10-07 | Different construct Different oligomeric state Different experimental conditions | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1361–1456(96 aa)
Fragment:PDZ2 DOMAIN
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR measurement conditions
pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR measurement conditions
pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR measurement conditions
pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR sample composition
1.0-5.0 MM OF N15-LABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED PEPTIDE
NMR sample composition
1.0-5.0 MM OF UNLABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED PEPTIDE
NMR sample composition
1.0-5.0 MM OF UNLABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED PEPTIDE
NMR sample composition
1.0-5.0 MM OF DOUBLE-LABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED
PEPTIDE
|
Resolution not provided |
| 1WCH Crystal structure of PTPL1 human tyrosine phosphatase mutated in colorectal cancer - evidence for a second phosphotyrosine substrate recognition pocket Deposited 2004-11-16 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2163–2477(315 aa)
Fragment:RESIDUES 2163-2477
|
Not recorded | PO4 PHOSPHATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION
|
Resolution 1.85 Å R-free 0.204 |
| 2M0Z cis form of a photoswitchable PDZ domain crosslinked with an azobenzene derivative Deposited 2012-11-09 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1361–1456(96 aa)
Fragment:PDZ 2 domain residues 1361-1456
|
Mutation:S1381C, E1436C | 33B 3,3'-(E)-diazene-1,2-diylbis{6-[(chloroacetyl)amino]benzenesulfonic acid} × 1 |
SOLUTION NMR
NMR measurement conditions
pH 6.8;298 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition
0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 4.3 % C12E5, 1.8 % n-hexanol, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 8.5 mg/mL Pf1 phage, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.75 mM [U-99% 13C; U-99% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2M10 trans form of a photoswitchable PDZ domain crosslinked with an azobenzene derivative Deposited 2012-11-09 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1361–1456(96 aa)
Fragment:PDZ 2 domain residues 1361-1456
|
Mutation:S1381C, E1436C | 33B 3,3'-(E)-diazene-1,2-diylbis{6-[(chloroacetyl)amino]benzenesulfonic acid} × 1 |
SOLUTION NMR
NMR measurement conditions
pH 6.8;298 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition
0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 4.3 % C12E5, 1.8 % n-hexanol, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 8.5 mg/mL Pf1 phage, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.75 mM [U-99% 13C; U-99% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 3LNX Second PDZ domain from human PTP1E Deposited 2010-02-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
1361–1456(96 aa)
Fragment:PDZ2 domain
Chain B
1361–1456(96 aa)
Fragment:PDZ2 domain
Chain C
1361–1456(96 aa)
Fragment:PDZ2 domain
Chain D
1361–1456(96 aa)
Fragment:PDZ2 domain
Chain E
1361–1456(96 aa)
Fragment:PDZ2 domain
Chain F
1361–1456(96 aa)
Fragment:PDZ2 domain
|
Not recorded | IOD IODIDE ION × 25 SCN THIOCYANATE ION × 14 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;28% PEG 3350, 0.2 M KI, 0.2 M NaSCN, 0.1 M NaAc, pH 4.5, hanging drop, temperature 298K, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.64 Å R-free 0.237 |
| 3LNY Second PDZ domain from human PTP1E in complex with RA-GEF2 peptide Deposited 2010-02-03 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain A
1361–1456(96 aa)
Fragment:PDZ2 domain
|
Not recorded | SCN THIOCYANATE ION × 6 SO4 SULFATE ION × 12 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;20% PEG 3350, 0.8 M (NH4)2SO4, 0.2 M NaSCN, 0.1 M Na citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.30 Å R-free 0.189 |
| 3PDZ SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E Deposited 1999-05-10 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1361–1456(96 aa)
Fragment:PDZ2 DOMAIN
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.8;293 K;Pressure 1
NMR sample composition
10% D2O/90% WATER
|
Resolution not provided |
| 5GLJ Crystal Structure of PDZ1 Domain of Human Protein Tyrosine Phosphatase PTP-Bas Deposited 2016-07-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
1086–1178(93 aa)
Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
Chain B
1086–1178(93 aa)
Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
Chain C
1086–1178(93 aa)
Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
Chain D
1086–1178(93 aa)
Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
|
Not recorded | CL CHLORIDE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Magnesium chloride hexahydrate , 0.1 M BIS-TRIS pH5.5, 25 % w/v Polyethylene glycol 3350
|
Resolution 1.60 Å R-free 0.206 |
| 7QCX Two-state liquid NMR Structure of a PDZ2 Domain from hPTP1E, apo form Deposited 2021-11-25 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1361–1456(96 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.8;298 K;Ionic strength (raw mmCIF value) 150;Pressure 1
NMR sample composition
2.0 mM [U-100% 13C; U-100% 15N] PDZ2 domain from hPTP1E, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided |
| 7QCY Two-state liquid NMR Structure of a PDZ2 Domain from hPTP1E, complexed with RA-GEF2 peptide Deposited 2021-11-25 | Different construct Different experimental conditions | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1361–1456(96 aa)
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.8;298 K;Ionic strength (raw mmCIF value) 150;Pressure 1
NMR sample composition
2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided |
| 7XTY Crystal Structure of the second PDZ domain from human PTPN13 in complex with APC peptide Deposited 2022-05-18 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1362–1456(95 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.8;289 K;0.1M citric acid (pH 3.5), 3M NaCl
|
Resolution 2.10 Å R-free 0.240 |
| 7XTY Crystal Structure of the second PDZ domain from human PTPN13 in complex with APC peptide Deposited 2022-05-18 | Different construct Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1362–1456(95 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.8;289 K;0.1M citric acid (pH 3.5), 3M NaCl
|
Resolution 2.10 Å R-free 0.240 |
11 other PDB entries and 12 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | PTN13_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–108; UniProt 1357–1464 |